Table 2.
Univariate and multivariate logistic regression analysis of prediction for successive bilateral SSNHL in patients with SSNHL (n = 248).
| Characteristics | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| p value | OR | 95% CI | p value | OR | 95% CI | |
| Age > 42 years | <0.01 | 0.332 | 0.148-0.748 | 0.809 | 0.882 | 0.319-2.440 |
| Gender (male) | >0.05 | 0.544 | 0.251-1.176 | |||
| NLR (>3.91) | <0.01 | 0.129 | 0.044-0.380 | <0.05 | 0.429 | 0.115-1.596 |
| PLR (>166.59) | <0.01 | 0.259 | 0.120-0.556 | <0.01 | 0.348 | 0.122-0.997 |
| MLR (>0.24) | <0.01 | 0.212 | 0.099-0.453 | <0.01 | 0.134 | 0.045-0.399 |
| LDL (>3.52) | <0.01 | 0.177 | 0.078-0.402 | <0.01 | 0.216 | 0.081-0.579 |
| HDL (<1.42) | <0.01 | 4.122 | 1.865-9.110 | <0.01 | 4.423 | 1.624-12.048 |
| Fibrinogen (>4.25) | <0.01 | 0.318 | 0.149-0.679 | >0.05 | 0.561 | 0.214-1.468 |
| Diabetes | <0.01 | 0.334 | 0.158-0.705 | <0.05 | 0.245 | 0.082-0.730 |
| Hypertension | >0.05 | 0.759 | 0.320-1.801 | |||
| Smoking | >0.05 | 0.775 | 0.360-1.668 | |||
| Alcohol consumption | >0.05 | 1.202 | 0.436-3.314 | |||
| Statins | >0.05 | 0.827 | 0.350-1.957 | |||
| Antihypertensive therapy | >0.05 | 0.849 | 0.344-2.093 | |||
SSNHL: sudden sensorineural hearing loss; OR: odds ratio; CI: confidential interval; NLR: neutrophil lymphocyte ratio; PLR: platelet lymphocyte ratio; MLR: monocyte lymphocyte ratio; LDL: low-density lipoprotein; HDL: high-density lipoprotein.